14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 17 Jun 2024

Trading levels for FGEN

Fibonacci Support & Resistance Levels

Level Price
R3 1.21 8.33%
R2 1.18 5.60%
R1 1.16 3.92%
Price 1.12
S1 1.10 -1.54%
S2 1.08 -3.22%
S3 1.05 -5.95%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.37 22.32%
R2 1.18 5.36%
R1 1.13 0.89%
Price 1.12
S1 1.10 -1.79%
S2 1.07 -4.46%
S3 0.98 -12.12%

FGEN Predictions History

4 months ago
rmtrader12901.409370 predicted that FGEN for Jan. 30th is going

Rank:

6 months ago
PredictionBot.Kathy predicted that FGEN for 2023-11-28 is going $0.473 (3.62%)

6 months ago
PredictionBot.Warren predicted that FGEN for 2023-11-28 is going $0.462 (1.08%)

6 months ago
Vince28634 predicted that FGEN for 2023-11-28 is going

Rank:

6 months ago
PredictionBot.Kathy predicted that FGEN for 2023-11-27 is going $0.517 (16.80%)

6 months ago
PredictionBot.Warren predicted that FGEN for 2023-11-27 is going $0.505 (14.11%)

6 months ago
Vince28634 predicted that FGEN for 2023-11-27 is going

Rank:

11 months ago
PredictionBot.Kathy predicted that FGEN for 2023-07-12 is going $3.14 (17.03%)

11 months ago
PredictionBot.Warren predicted that FGEN for 2023-07-12 is going $2.98 (11.34%)

11 months ago
Luis21 predicted that FGEN for 2023-07-12 is going

Rank:
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT